Brian Nichols

Brian Nichols

InvestorPlace Contributor

Recent Articles

Verizon Communications Inc.: VZ Is Poised to Dominate 5G

By Brian Nichols, InvestorPlace Contributor

Verizon's lead with 5G is even more promising and lucrative than you ever imagined, and is likely to make VZ stock a dominant force in the years ahead.

Nokia Corp (ADR): NOK Stock Is a “Must Buy”

By Brian Nichols, InvestorPlace Contributor

NOK stock goes higher behind $1.5 billion China Mobile deal, showing the effect of Nokia's acquisition of Alcatel Lucent (ALU).

Bitauto Hldg Ltd (ADR) (BITA): This Chinese Stock Could Double

By Brian Nichols, InvestorPlace Contributor

Recent investments from Baidu, Tencent and JD.com tell you that Bitauto (BITA) stock is a buy that could double ... in time.

7 Stocks to Sell and Take Profits on Now!

By Brian Nichols, InvestorPlace Contributor

These seven stocks have had good runs, but the rally is unsustainable for a variety of reasons. It's time to sell these stocks now!

Fitbit Inc: Why This Quarter Is Essential for FIT Stock

By Brian Nichols, InvestorPlace Contributor

FIT has a great opportunity this quarter to become a more balanced company, and if so, it will do wonders for Fitbit stock.

Acadia Pharmaceuticals Inc.: 7 Companies That Could Buy ACAD

By Brian Nichols, InvestorPlace Contributor

Acadia Pharmaceuticals likely has many interested buyers on the line for its drug Nuplazid, which is good news for ACAD stock.

Valeant Pharmaceuticals and LendingClub Have A LOT in Common (NYSE: LC)

By Brian Nichols, InvestorPlace Contributor

LendingClub is not a market favorite right now, but just hang tight, there are more than a few reasons why LC stock will be back on top.

Yahoo! Inc.: Softbank Gives More Bad News to YHOO Stock Owners

By Brian Nichols, InvestorPlace Contributor

Softbank's decision to sell $7.9 billion worth of Alibaba stock has bigger implications for YHOO stock than investors realize.

Valeant Pharmaceuticals Intl Inc: Can Papa’s Lead Save VRX Stock?

By Brian Nichols, InvestorPlace Contributor

Joseph Papa has been unfairly criticized as the new CEO of Valeant (VRX). When you look at his past, it is clear that he is the man for the job.

Michael Kors Holding Ltd: Analysts’ Calls on KORS Stock Conflict

By Brian Nichols, InvestorPlace Contributor

Wedbush and Piper Jaffray on opposite ends of the spectrum when it comes to KORS stock, and ironically, both are probably right.

Load More